Belite Bio, Inc (BLTE) Stock Price, News, Quote & History

By Yahoo! Finance   |   3 months ago
Belite Bio, Inc (BLTE) Stock Price, News, Quote & History

Belite Bio is a biopharmaceutical company in the US focusing on developing therapies for retinal degenerative diseases. Their lead product LBS-008 targets Stargardt disease, while LBS-009 is in preclinical development for liver diseases and diabetes.

Read More

Did you find this insightful?